Concepedia

Dual-targeted NIS polyplexes—a theranostic strategy toward tumors with heterogeneous receptor expression

Sarah Urnauer, Kathrin A. Schmohl, Mariella Tutter, Christina Schug, Nathalie Schwenk, Stephan Morys, Sibylle Ziegler, Peter Bartenstein, Dirk‐André Clevert, Ernst Wagner,

Gene Therapy · 2019 · 31 citations · 47 references

DOIFull text

Open access

Concepts

References

47

Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial

Anthony B. El-Khoueiry, Bruno Sangro, Thomas Yau et al. · The Lancet · 2017 · 4.3K citations · Full text

, , +13

Cloning and characterization of the thyroid iodide transporter

Ge Dai, Orlie Levy, Nancy Carrasco · Nature · 1996 · 1.1K citations

, , +9

Translational Implications of Tumor Heterogeneity

Clinical Cancer Research · 2015 · 527 citations · Full text

, , +17

Cross-talk between Epidermal Growth Factor Receptor and c-Met Signal Pathways in Transformed Cells

Minji Jo, Donna B. Stolz, James E. Esplen et al. · Journal of Biological Chemistry · 2000 · 345 citations · Full text

, , +16

Remission of Disseminated Cancer After Systemic Oncolytic Virotherapy

Stephen J. Russell, Mark J. Federspiel, Kah-Whye Peng et al. · Mayo Clinic Proceedings · 2014 · 272 citations

, , +14